Efficacy and safety of ipilimumab in patients with pre-treated, uveal melanoma.

Maio, M; Danielli, R; Chiarion-Sileni, V; Pigozzo, J; Parmiani, G; Ridolfi, R; De Rosa, F; Del Vecchio, M; Di Guardo, L; Queirolo, P; Picasso, V; Marchetti, P; De Galitiis, F; Mandalà, M; Guida, M; Simeone, E; Ascierto, P A

Maio, M; Danielli, R; Chiarion-Sileni, V; Pigozzo, J; Parmiani, G; Ridolfi, R; De Rosa, F; Del Vecchio, M; Di Guardo, L; Queirolo, P; Picasso, V; Marchetti, P; De Galitiis, F; Mandalà, M; Guida, M; Simeone, E; Ascierto, P A.

Affiliation

Maio M; Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Tuscan Cancer Institute, Siena.

Ann Oncol ; 24(11): 2911-5, 2013 Nov.

Article in En | MEDLINE | ID: mdl-24067719

Subject(s)

Antibodies, Monoclonal/administration & dosage; Melanoma/drug therapy; Skin Neoplasms/drug therapy; Uveal Neoplasms/drug therapy; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal/adverse effects; Disease-Free Survival; Female; Humans; Ipilimumab; Male; Melanoma/mortality; Melanoma/pathology; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Skin Neoplasms/mortality; Skin Neoplasms/pathology; Treatment Outcome; Uveal Neoplasms/mortality; Uveal Neoplasms/pathology

Key words

efficacy; expanded access programme; ipilimumab; metastatic melanoma; safety; uveal melanoma

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Uveal Neoplasms / Melanoma / Antibodies, Monoclonal Type of study: Clinical_trials Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2013 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google